Sulayman Dib-Hajj
Overview
Explore the profile of Sulayman Dib-Hajj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Becker J, Effraim P, Dib-Hajj S, Rittner H
Pain Rep
. 2023 Nov;
8(6):e1100.
PMID: 37928204
Introduction: During the past 2 decades, basic research deciphering the underlying mechanisms of nociception and chronic pain was thought to finally step beyond opioids and nonsteroidals and provide patients with...
2.
Almomani R, Sopacua M, Marchi M, Sleczkowska M, Lindsey P, de Greef B, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175987
Neuropathic pain is a frequent feature of diabetic peripheral neuropathy (DPN) and small fiber neuropathy (SFN). Resolving the genetic architecture of these painful neuropathies will lead to better disease management...
3.
Marchi M, Salvi E, Andelic M, Mehmeti E, DAmato I, Cazzato D, et al.
Pain
. 2023 Apr;
164(9):2048-2059.
PMID: 37079850
No abstract available.
4.
Estacion M, Liu S, Cheng X, Dib-Hajj S, Waxman S
Front Pharmacol
. 2023 Mar;
14:1138556.
PMID: 36923357
Chronic pain is highly prevalent and remains a significant unmet global medical need. As part of a search for modulatory genes that confer pain resilience, we have studied two family...
5.
Andelic M, Salvi E, Marcuzzo S, Marchi M, Lombardi R, Cartelli D, et al.
Brain
. 2023 Feb;
146(7):3049-3062.
PMID: 36730021
Personalized management of neuropathic pain is an unmet clinical need due to heterogeneity of the underlying aetiologies, incompletely understood pathophysiological mechanisms and limited efficacy of existing treatments. Recent studies on...
6.
Ghovanloo M, Estacion M, Higerd-Rusli G, Zhao P, Dib-Hajj S, Waxman S
Br J Pharmacol
. 2022 Mar;
179(15):4010-4030.
PMID: 35297036
Background And Purpose: Cannabigerol (CBG), a non-psychotropic phytocannabinoid and a precursor of ∆ -tetrahydrocannabinol and cannabidiol, has been suggested to act as an analgesic. A previous study reported that CBG...
7.
Labau J, Alsaloum M, Estacion M, Tanaka B, Dib-Hajj F, Lauria G, et al.
Front Pharmacol
. 2022 Jan;
12:791740.
PMID: 34992539
Lacosamide, developed as an anti-epileptic drug, has been used for the treatment of pain. Unlike typical anticonvulsants and local anesthetics which enhance fast-inactivation and bind within the pore of sodium...
8.
Alsaloum M, Labau J, Sosniak D, Zhao P, Almomani R, Gerrits M, et al.
J Neurophysiol
. 2021 Jul;
126(3):827-839.
PMID: 34320850
Small fiber neuropathy (SFN) is a common condition affecting thinly myelinated Aδ and unmyelinated C fibers, often resulting in excruciating pain and dysautonomia. SFN has been associated with several conditions,...
9.
Renthal W, Chamessian A, Curatolo M, Davidson S, Burton M, Dib-Hajj S, et al.
Neuron
. 2021 May;
109(9):1426-1429.
PMID: 33957072
Chronic pain is a disabling disease with limited treatment options. While animal models have revealed important aspects of pain neurobiology, therapeutic translation of this knowledge requires our understanding of these...
10.
Almomani R, Marchi M, Sopacua M, Lindsey P, Salvi E, de Koning B, et al.
PLoS One
. 2021 Mar;
16(3):e0248250.
PMID: 33651841
[This corrects the article DOI: 10.1371/journal.pone.0238467.].